Apparatus New Findings Confirm: Excellent Data On This Bipotent Antibody Drug Against Ovarian Cancer! Apr 23, 2025 Apr 23, 2025 The results of a new study show that Ubamatamab, a bispecific antibody drug, has shown excellent results and a good safety profile in patients with ovarian cancer.
